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ABSTRACT (336 words) 
Background: Tobacco smoking is extremely prevalent in people with severe mental illness 
(SMI) and has been recognised as the main contributor to widening health inequalities in this 
population. Historically, smoking has been deeply entrenched in the culture of mental health 
settings in the UK, and until recently, smokefree policies tended to be only partially 
implemented. However, recent national guidance DQGWKHJRYHUQPHQW¶VWREDcco control plan 
now calls for the implementation of complete smokefree policies. Many mental health Trusts 
across the UK are currently in the process of implementing the new guidance, but little is 
known about the impact of and experience with policy implementation.  
Methods: This paper reports findings from a mixed-methods evaluation of policy 
implementation across 12 wards in a large mental health Trust in England. Quantitative data 
were collected and compared before and after implementation of NICE guidance PH48 and 
referred to 1) identification and treatment of tobacco dependence, 2) smoking-related 
incident reporting, and 3) prescribing of psychotropic medication. A qualitative exploration of 
the experience of inpatients was also carried out. Descriptive statistical analyses were 
performed, and the feasibility of collecting relevant and complete data for each quantitative 
component was assessed. Qualitative data were analysed using thematic framework 
analysis.   
Results: Following implementation of the complete smokefree policy, increases in the 
numbers of patients offered smoking cessation advice (72% compared to 38%) were 
identified.  While incident reports demonstrated a decrease in challenging behaviour during 
the post-PH48 period (6% compared to 23%), incidents relating to the concealment of 
smoking materials increased (10% compared to 2%).  Patients reported encouraging 
changes in smoking behaviour and motivation to maintain change after discharge.  However, 
implementation issues challenging full policy implementation, including covert facilitation of 
smoking by staff, were reported, and difficulties in collecting relevant and complete data for 
comprehensive evaluation purposes identified.  
Conclusions: Overall, the implementation of complete smokefree policies in mental health 
settings may currently be undermined by partial support from staff. Strategies to enhance 
support and the establishment of suitable data collection pathways to monitor progress are 
required.  
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BACKGROUND 
Rates of smoking among people with severe mental illness (SMI) are two to three times 
higher than among the general population and can reach up to 70% among hospitalised 
mental health patients[1]. Consequently, smokers with mental illness experience significant 
reductions in life expectancy due to smoking-related morbidity and mortality, with an average 
of 17 years of life lost to prematurely to conditions that are caused or exacerbated by 
smoking[2]. Due to metabolic interactions between hydrocarbon agents within tobacco 
smoke and the human liver enzyme CYP2A6, smokers with mental illness can require up to 
double the dosage of psychotropic medication to reach a therapeutic range, meaning that 
monitoring and adjustment of dosages is necessary for certain medications to prevent 
potential medication toxicity, for example in the case of the atypical antipsychotic 
clozapine[1]. Despite evidence that people with mental illness are similarly motivated to quit 
to the general population[3] and can successfully do so when provided with evidence-based 
support[4], tobacco use within inpatient mental health settings is historically and culturally 
deeply embedded[1, 5]. Addressing smoking among mental health patients has been 
identified as a long neglected area, and as essential in efforts to reduce health inequalities in 
this disadvantaged population[1].  Although mental health settings in England became 
µVPRNHIUHH¶E\law in July 2008, meaning that any smoking indoors was prohibited after that 
date, research identified the persistence of smoking as the norm in the context of blanket 
exemptions that were granted for patients to smoke in courtyards or other outdoor spaces on 
mental health Trust premises[6]. The provision of staff-VXSHUYLVHGUHJXODUµVPRNLQJEUHDNV¶
for patients was estimated at an annual cost of between £18,250 and £86,870, per ward 
dependent upon the seniority of staff[7, 8]. Additionally, there was an indication that the 
facilitation of regular smoking breaks within mental health settings might increase incidents 
of challenging behaviours among patients and could potentially lead to  increased use of 
prescribed pro re nata (µas needed¶) medication administration[8]. 
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In 2013, the UK National Institute of Health and Clinical Excellence (NICE) published public 
health guideline 48 (PH48) for smoking cessation in secondary care, acute mental health, 
and maternity settings[9]. The guidance recommends the implementation and enforcement 
of completely smoke free hospital sites without exemptions, comprehensive policies that 
promote and support smoking cessation and temporary abstinence, and the development of 
integrative treatment pathways for tobacco dependence. Implementation across mental 
health Trusts in England is currently underway; the JRYHUQPHQW¶Vtobacco control plan for 
England 2017[10] sets the achievement of guidance implementation by the end 2018 as a 
target for all mental health Trusts. IQYLHZRIWKHKLVWRULFµVPRNLQJFXOWXUH¶LQPHQWDOKHDOWK
settings[5, 11] that involves complex psychosocial dynamics between patients, and patients 
and staff, and the powerful links between smoking and mental illness[1, 12], the guidance 
acknowledges various challenges to be likely to arise in the context of policy implementation 
and states the importance of monitoring outcomes in this regard. Although many mental 
health Trusts across England have implemented NICE guidance PH48 since its publication 
or are in the process of doing so, little is known so far about implementation impact and 
experiences in England.  This paper presents the findings of a mixed-methods evaluation 
prior to and following the implementation of NICE PH48 in a large Northern NHS mental 
health Trust. Specifically, the evaluation aimed to: 
1) Assess the completeness of recording of smoking-related data, including smoking status 
and smoking cessation/abstinence treatment offered and received; 
2) Investigate potential changes in smoking-related incidents reported prior to and following 
smokefree policy implementation; 
3) Compare average doses of psychotropic medication affected by tobacco smoking for 
inpatients before and after smokefree policy implementation; 
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4) E[SORUHLQSDWLHQWV¶H[SHULHQFHZLWKWKHVPRNHIUHHSROLF\DQGLWVLPSDFWRQVPRNLQJ
behaviour and on intentions relating to smoking after discharge following smokefree policy 
implementation; 
5) Review the availability of relevant and complete data for the purposes of evaluation, and 
develop recommendations.  
METHODS 
Study Design 
The mixed-methods evaluation consisted of two parts: 1) the collection and comparison of 
TXDQWLWDWLYHGDWDPHDVXULQJSDWLHQWV¶VPRNLQJVWDWXVDQGVPRNLQJ-related treatment 
recordings, smoking-related incident reporting, and antipsychotic medication prescribing pre- 
and post policy implementation; and 2) a qualitative exploration of inpatient experience 
following smokefree policy implementation, using face-to-face interviews, after policy 
implementation.   
Setting and participants 
The evaluation was set within a large mental health and learning disability NHS Foundation 
Trust in the North of England, providing acute inpatient treatment on twelve mental health 
inpatient wards (five acute wards, two rehabilitation wards, two dementia wards, two older 
adult wards, and a peri-natal ward), located across three sites and housing 156 patients in 
total. Prior to the implementation of NICE PH48, the Trust smoke free policy permitted 
regular escorted smoking breaks on-site for patients detained under the Mental Health Act, 
in designated outdoor smoking areas.  For non-detained patients and those granted Section 
17 leave under the Mental Health Act 1983, unescorted smoking breaks were permitted off 
the Trust site. Following NICE guidance PH48, the Trust revised its smokefree policy to 
prohibit smoking anywhere on the Trust premises, and to discontinue the escorting of 
detained patients to spaces where they could smoke. No exemptions to the smokefree policy 
were to be DOORZHG7KHSROLF\VWLSXODWHGWRUHFRUGDOOSDWLHQWV¶VPRNLQJVWDWXVRQDGPLVVLRQ
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and to offer Nicotine Replacement Therapy (NRT) and behavioural support to help smokers 
quit or manage their withdrawal symptoms during the hospital stay, using an in-house 
µ+HDOWKDQG:HOOEHLQJ6HUYLFH¶ZLWKWUDLQHGVPRNLQJFHVVDWLRQDGYLVRUV 
Procedures 
Data collection and analyses 
Quantitative measures were collected over a period of two months prior to the 
implementation of NICE guidance PH48 (April 2016), in February and March 2016, and 
again over a period of two months following guidance implementation, in May and June 
2016. While the pre- and post-evaluation design was chosen in line with a common 
methodological approach in the relevant literature[13], the data collection periods of two 
months before and after implementation reflected a pragmatic choice made in light of a 
number of constructions arising in the context of this pragmatic project. The collected data 
included recordings of: 1) basic demographic patient data and patient smoking status on 
admission; 2) delivery of brief advice and treatment (including NRT) for temporary 
abstinence and smoking cessation; 3) prescriptions of psychotropic medications whose 
metabolism is known to be significantly affected  by tobacco smoking/quitting, and the 
prescribed regular and pro re nata µDVQHHGHG¶dosages among patients identified as 
smokers; and 4) smoking-related incidents. In addition, we endeavoured to collect additional 
data not routinely collected RQSDWLHQWV¶FLJDUHWWHFRQVXPSWLRQRQDGPLVVLRQDQGDW
discharge (to identify changes in smoking behaviour during the admission period) on two 
pilot wards. The assessment of feasibility to collect relevant and complete data for each of 
the quantitative components took place throughout the study for each quantitative 
component and is reported in the relevant sections. Qualitative data relating to patients 
experience after smokefree policy implementation were collected in the summer of 2016. 
Further methodological detail relating to data collection for each study element is given 
below.  
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
7 
 
Identification and treatment of tobacco dependence  
Anonymised demographic data, primary mental health diagnosis, legal status (i.e. voluntary 
admission or detained under the Mental Health Act), length of admission, and smoking 
status information were obtained from electronic patient records for all patients admitted to 
the 12 participating wards between 01 February and 30 March 2016 for the pre-
implementation phase, and between 01 May and 30 June 2016 for the post-implementation 
phase.  Smoking status, if recorded, was defined on the electronic Trust V\VWHPDVµFXUUHQW¶
µIRUPHU¶µQHYHU¶RUµXQNQRZQ¶:KHUHSDWLHQWVLQGLFDWHGthey had been smokers on 
admission, information regarding the delivery of smoking cessation advice, offers of 
treatment for tobacco dependence, and the type of treatment offered, were recorded. Data 
were coded and entered in IBM Statistical Package for Social Sciences (SPSS) and 
descriptively analysed for frequencies, proportions, and means including standard deviations 
(SD). 
Prescribing of psychotropic medication and nicotine replacement therapies 
A data set comprising prescriptions of psychotropic medications most notably influenced by 
smoking and smoking cessation[14] was created based on prescription transcripts for 
patients admitted for the pre- and post- implementation periods. Medication doses and 
frequency of administration were recorded in IBM SPSS version 22 for each evaluation 
period.  Prescribed daily doses, prescribed four-weekly doses, and maximum daily pro re 
nata doses of medication were determined for each patient. Data were aggregated to 
calculate the mean dose for each main type of psychotropic medication prescribed during 
the pre-PH48 implementation period and the post-PH48 implementation period across all 
participating wards.  Standard deviations were calculated where appropriate. In view of the 
non-normal distribution, non-parametric Mann-Whitney U tests were used to measure the 
direction and significance of changes in doses between the pre- and post-PH48 
implementation periods.  Statistical significance was defined as p<0.05. In addition, data on 
prescribed NRT were compiled from a review of patient pharmacy records pre- and post- 
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implementation. Frequencies, proportions, and median (including interquartile range) 
dosages are presented.  Meaningful statistical comparison of the pre- and post-
implementation data was not possible due to the scarcity of NRT prescription data.  
Smoking-related incidents 
Data relating smoking-related incidents for each ward were obtained from the Trusts 
electronic incident reporting system, Datrix, for the pre-implementation period and the post-
implementation period and transferred into Microsoft Excel for data management.  Searches 
were made using smoking and incident-related key words and their synonyms[8].  The 
narrative accompanying each retrieved incident report was reviewed to ensure its relevance 
and those reports identified as not relating to smoking were excluded from analysis. A 
coding framework was developed in which to record relevant manifest content. Manifest 
content is µovertly presented and quantifiable¶, as opposed to latent content that requires 
interpretation of underlying surface level data[15].  Manifest content analysis allows for the 
broad observation of themes throughout a large data sample, and uses quantitative analysis 
to identify trends. An initial structure was established from a priori knowledge of the topic; 
further thematic codes were added to the coding frame as they emerged from readings of 
the incident reports.  Relevant manifest content of each smoking related incident report were 
recorded using the coding frame. Data were analysed in Microsoft Excel.  Descriptive 
statistics were used to obtain frequencies and proportions.   
Levels of incident severity were defined by the Trust reporting system as 0= no harm 
caused; 1=low severity (resulting in increased patient observation or minimal changes to 
care plans); 2=moderate severity (short-term harm caused); and 3=high severity (longer-
term harm caused). Data contained within each incident report were reviewed and a rating of 
harm applied to the incident.  Data were analysed in Microsoft Excel and frequencies and 
proportions obtained. 
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PatientV¶ experience with smokefree policy implementation 
An opportunistic approach to participant recruitment was adopted for the semi-structured 
face-to-face interview studyJXLGHGE\SDWLHQWV¶PHQWDOKHDOWKVWDWXVDQGWKHLULQWHUHVWLQ
taking part. Patients from all participating wards, who reported to be current smokers on 
admission, and who were able to provide informed consent, were identified in liaison with the 
multi-disciplinary teams in the week prior to discharge and eligibility was confirmed with 
patients¶ care teams. Potential participants were initially approached by a member of their 
care team with study information. Interviews were conducted in a private area of the ward 
with informed written consent. Separate consent was obtained for the audio recording of the 
interview and where consent was refused in-depth notes of participant responses were 
made by the researcher. Demographic patient data were collected and a schedule of topics 
guided interview discussionsIRFXVVLQJRQSDWLHQWV¶SDVWDQGSUHVHQWVPRNLQJEHKDYLRXUV
their perceptions of a smokefree inpatient stay, and intentions relating to smoking behaviour 
after discharge, while allowing novel themes to emerge during the conversation.   
Accounts were generated from participants using conversational prompts.  Summation was 
employed during discussion to ensure researcher understanding and to provide the 
opportunity for participants to correct any accounts, thus improving accuracy and validity. 
Demographic data were coded and entered into Microsoft Excel and analysed descriptively 
for frequencies and proportions. Narrative data were transcribed verbatim and analysed 
using a thematic framework approach[16]. Transcripts were read repeatedly.  A priori and 
emergent points were developed into a framework from which codes were derived and 
applied to the data. In order to establish coherence of the framework, interview transcripts 
were read and coded independently by a second researcher (LH).  Where minor differences 
in relation to coding arose, these were settled through discussion.    
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RESULTS 
Patient characteristics 
Patient characteristics for both the pre- and post-implementation cohorts are presented in 
Table 1. 
Table 1: ABOUT HERE 
 
Identification and treatment of tobacco dependence 
Recording of patients¶ smoking status 
Among the 150 patients admitted for treatment of acute mental illness during the pre-PH48 
implementation period, 141 (94.0%) were asked about smoking status on admission, and 
from the 165 patients in the post-PH48 implementation phase, 139 (84.2%) received similar 
enquiries.  Table 2 details the smoking status of patients for both the pre- and post-PH48 
implementation periods. :HZHUHXQDEOHWRFROOHFWDGGLWLRQDOLQIRUPDWLRQRQSDWLHQWV¶
cigarette consumption after admission and at discharge to assess changes in smoking 
behaviour during admission, as clinicians did not record it as planned. Therefore, we were 
unable to to present appropriate data relating to this outcome in the context of this 
evaluation.  
Table 2: ABOUT HERE 
 
Characteristics of smokers identified 
Among the 70 (49.6%) smokers identified during the pre-PH48 period, 44 (62.9%) were male 
and 26 (37.1%) were female and had a mean age of 37.4 (SD 12.84) years.  Almost two-
thirds of smokers (n=42, 60.0%) were detained for treatment under the Mental Health Act.  
Fourteen (20.0%) patients had previously experienced admission for treatment of mental 
disorder and the mean duration of admission was 23.0 (SD 15.73) days.  During the post-
PH48 implementation period, among the 65 (46.7%) identified smokers, 38 (58.5%) were 
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male and 27 (41.5%) were female with a mean age of 43.3 (SD 14.79) years.  Over three-
quarters (n=50, 76.9%) of patients were detained under the mental health act and 24 
(36.9%) had previously experienced admission for treatment of acute mental disorder.  The 
mean duration of admission was 34.9 (SD 20.6) days. 
Recording of brief advice and treatment for smoking cessation/temporary abstinence 
During the pre-PH48 implementation period, 57 (38.0%) of the 70 current smokers received 
advice relating to smoking, and of these, under a third (n=21, 30.0%) were offered an 
intervention to support cessation or temporary abstinence.  Interventions offered to smokers 
included: the prescribing of NRT (n=5, 23.8%) or referral to external stop smoking services 
(n=16, 76.2%). Following implementation of PH48, 47 (72.7%) of the 65 smokers identified 
received advice, and of these, 59.1% (n=39) were offered treatment for tobacco dependence 
through the in-house Health and Wellbeing service.  The majority (n=38, 97.4%) of patients 
who received an offer of treatment were recorded as being provided with NRT.   
Prescriptions of nicotine replacement therapies 
During the pre-implementation period, pharmacy records showed that five patients (7% of 
smokers identified) had received prescriptions of NRT.  Four were prescribed nicotine 
patches providing a median dose of 21 mg (IQR 12.7-21.0mg) and one patient received 
combination NRT comprising a 21mg nicotine patch and a 15mg inhalator. During the post-
implementation period, 38 patients (58% of smokers identified) were recorded as having 
been being provided with NRT LQSDWLHQWV¶QRWHVDOWKRXJK157SUHVFULSWLRQVFRXOGEH
identified only for 11 (28.9%) of those. . Six (54.4%) received a nicotine patch providing a 
median dose of 21mg (IQR 19.5-25.0mg).  Three (27.3%) patients were prescribed a 15mg 
nicotine inhalator, and two (18.2%) patients received combination NRT comprising a 21mg 
patch and a 15mg nicotine inhalator. The numbers were too small to perform meaningful 
statistical analysis.  
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
12 
 
Psychotropic medication prescribing 
Substantial difficulties were encountered in collecting the relevant data for this study 
component. The challenges arose from the circumstance that medication data were not 
available electronically, and that storage locations for paper case notes and availability of 
authorised staff to liaise in retrieving notes varied greatly. Despite persistent attempts to 
retrieve the information, only partial data sets could be developed after extracting information 
from paper case notes: for the pre-implementation period, 141 out of 150 (94%) medication 
transcripts were analysed. For the post-implementation period, only 82 out of 165 (49.7%) of 
medication transcripts could be retrieved before the end of the project. Results of the 
analysis below should be considered with this limitation in mind.  
Seventy-six of 141 admitted patients (53.9%), for whom medication transcripts could be 
retrieved, had been prescribed psychoactive drugs significantly affected by components of 
tobacco smoke during the pre-implementation period.  The majority (n=59, 77.6%) of these 
medications were antipsychotics; 18 (23.7%) were benzodiazepines; and 14 (18.4%) were 
antidepressants.  Data relating to the post-implementation period identified 40 of 82 patients 
(48.8%), for whom records were retrieved, who were prescribed relevant psychoactive 
drugs.  Two-thirds (n=27, 67.5%) of these medications were antipsychotics; ten (25.0%) 
were antidepressants; and five (12.5%) were benzodiazepines.  Mean daily dosages, and 
where appropriate in the case of longer acting drugs (indicated by an asterix), four weekly 
doses for each individual medication, were calculated with standard deviations (SD) (Table 
3). 
Non-significant decreases were identified in the dosages prescribed for the anti-depressant 
Mirtazapine, for the benzodiazapine diazepam, and for the antipsychotics clozapine, 
duloxetine, haloperidol, olanzapine, and zuclopenhixol, and a non-significant increase was 
found in the prescribing of the longer acting injectable haloperidol depot.  Mann-Whitney 
tests found that the aggregated dosage of the antipsychotic zuclopenhixol deconate 
increased significantly over the post-PH48 period (U=27.0, p =0.030). 
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Table 3: ABOUT HERE 
 
Smoking related incidents 
Quantitative content analysis 
Smoking-related incidents were retrieved and categorised for both the pre- (n=52) and post-
PH48 (n=394) implementation periods (Table 3). Incidents for both periods were reviewed 
together in order to develop categories of incident type resulting from or related to tobacco 
use.  Four categories were identified:  1) illicit smoking; 2) concealing paraphernalia and 
other policy breaches, 3) wider safety concerns; and 4) challenging behaviours.    
Illicit smoking 
Twenty-eight (53.8%) incidents for the pre-PH48 period reported illicit smoking indoors.  
Twenty-one (75.0%) of these incidents occurred in relation to patients smoking in bedrooms; 
three (10.7%) were related to patients smoking in bathrooms; and four (14.3%) concerned 
patients smoking within shared ward areas, such as kitchen areas.  The majority (n=322, 
81.7%) of incidents during the period following the implementation of PH48 pertained to illicit 
smoking, over half (n=168, 52.2%) indoors: 83 (49.4%) occurred in patients¶ bedrooms; 52 
(31.0%) took place in patientV¶ bathrooms; and 33 (19.6%) were in relation to patients 
smoking in shared areas of the ward.  One-hundred and fifty-four (47.8%) of incidents were 
recorded as smoking in the outside space on Trust premises. Fifty-one (33.1%) incidents of 
smoking by patients escorted by staff on the TTrust site were recorded and 103 (66.8%) 
incidents occurred when patients were unaccompanied. The majority (n=92, 89.3%) of 
outside patient smoking was identified as taking place within the wider grounds of the TTrust 
site.  Smoking within secure outside ward spaces (such as internal courtyards) was 
documented in eleven (10.7%) reports. 
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Concealing smoking paraphernalia and other policy breaches 
Prior to the implementation of PH48, one (1.9%) incident was recorded describing an 
episode of concealment of tobacco by a patient when returning from leave.  Following the 
implementation of PH48, almost 10% (n=39) of all smoking-related incidents were 
concerned with concealment.  Almost all (n=38, 97.4%) of these related to patients 
concealing tobacco or smoking paraphernalia.  Fifteen (39.5%) concealments were identified 
LQSDWLHQWV¶EHGURRPVSDWLHQWVZHUHZLWQHVVHGFRQFHDOLQJWREDFFRZLWKLQWKH
grounds of the unit; seven (18.4%) patients were reported as attempting to conceal tobacco 
and/or lighters about their person; and concealed lighters were found within the general 
areas of the ward on three (7.9%) occasions.  The one (2.6%) remaining policy breach 
incident related to a visitor providing a patient with pouches of tobacco. 
Wider safety concerns 
Ten (19.2%) of the 52 recorded incidents prior to the implementation of PH48 related to 
µVDIHW\¶LQWKHVHQVHRIKDYLQJSRWHQWLDOLPSDFWRQSDWLHQWDQGVWDIIVDIHW\6L[
related to patients going missing/absconding from the ward in order to smoke or to purchase 
tobacco without leave. Four (40.0%) further incident reports documented the use of 
electricity by patients as an ignition source for the lighting of cigarettes.  Following the 
implementation of PH48, eight (2.0%) incidents relating to safety were identified.  These 
comprised the use of electricity as a source of ignition, used to light cigarettes (n=4, 50.0%) 
and patients absconding from the ward in order to acquire or smoke tobacco (n=4, 50.0%) 
Challenging behaviour 
In the pre-implementation period, twelve (23.2%) incidents were identified as concerning 
challenging behaviours resulting from the use of tobacco or smoking-related arrangements 
within the wards.  These incidents comprised reports of:  physical violence by patients 
against staff (n=7, 58.4%); verbal aggression directed towards staff (n=3, 25.0%); and 
damage to Trust property (n=1, 8.3%).  One (8.3%) incidence of patient self-harm was also 
UHSRUWHGDVDUHVXOWRIEHLQJGHQLHGDµVPRNLQJEUHDN¶)ROORZLQJLPSOHPHQWDWLRQRI3+
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challenging patient behaviours accounted for approximately 6% (n=23) of tobacco related 
incidents.  These included: physical violence towards staff by patients (n=5, 20.0%); verbal 
aggression directed at clinical staff by patients (n=5, 20.0%); damage to Trust property (n=7, 
28.0%); harassment or bullying between patients (n=4, 16.0%); patient harassment of staff 
(n=1, 4.0%) and patient harassment of visitors (n=1, 4.0%).  . 
Severity of harm resulting from smoking-related incidents 
Levels are harm resulting from smoking related incidents were calculated for both periods.  
Among the reports documenting smoking-related incidents during the pre-PH48 period, the 
majority (n=45, 86.5%) resulted in no harm being caused; five (9.6%) reports were classed 
as low severity, indicating that minimal harm was caused; and one (1.9%) incident of 
physical violence against staff was recorded as moderate in severity, resulting in short-term 
harm, requiring medical treatment.  The great majority (n=378, 95.9%) of the incidents 
reported during the post-PH48 period were rated as resulting in no harm being caused to 
staff, patients, or the general public, while 1LQFLGHQFHZHUHFODVVHGDµORZ¶VHYHULW\
indicating that minimal harm resulted. No moderate or severe cases of harm were identified.  
 
Patient experience 
Participant characteristics 
Nine patients were recruited over several months from the participating rehabilitation and 
acute adult mental health wards. Recruitment in this study population and setting was 
challenging and occurred in liaison with wards staff; a formal record to document recruitment 
rates was not kept. Of the nine recruited patients, eight consented to audio recording; in the 
remaining case, detailed notes were taken by the interviewer.  Interviews lasted between 30 
and 40 minutes. Six (66.7%) participants were male and three (33.3%) were female. The 
mean age was 32.6 (SD 5.81) years. Four reported a primary diagnosis of schizophrenia, 
one of bipolar disorder, and one of psychosis; the remaining three diagnoses were 
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undisclosed or unknown. Two participants had quit smoking since admission to the inpatient 
ward, and all others, with one exception, reported to smoke significantly less than they had 
before admission. Those who still smoked consumed between five and 40 cigarettes daily 
[mean 16.0 (SD 10.50)].  Motivation to make a quit attempt among the seven smokers was 
reported with a mean rating of 4.3 (SD 2.82) from a maximum of ten points on a visual 
analogue scale.  Confidence in successfully achieving cessation, if a quit attempt was made, 
was rated at a mean of 6.2 (SD 2.72) from a maximum of ten points.  Table 4 provides 
further details of participant demography and smoking behaviours. 
Thematic framework analysis 
Interview data were analysed with reference to pre-identified topics and emerging themes 
and grouped into four main thematic areas: 1) past and present smoking behaviours: 
adjusting to the smokefree policy; 2) policy realities: enforcement and support; 3) challenges 
related to cessation and abstinence; and 4) motivation to quit and thoughts on smoking after 
discharge. As anticipated in this patient population, the flow of conversations and depth of 
data gathered during the interviews varied, with some communication problems being 
apparent in some interviews. The analysis below should be viewed as indicative of relevant 
content and as preliminary, suitable to inform further exploration.  
Theme 1: Past and present smoking behaviour: adjusting to the smokefree policy 
Most interview participants described taking up smoking early in life, often prompted by peer-
pressure or even facilitated by their family. With one exception, all reported having attempted 
to quit smoking at least once in their lives previously, with most having succeeded for at 
least brief periods of time. Notably, seven of nine participants had either quit or reduced their 
smoking as a result of admission to a smokefree ward: two patients reported complete 
abstinence with only rare lapses at the time of interview, and six reported reduction of 
consumption, three of whom substantial, from over 20 per day to less than five. Two patients 
reported smoking more than they used to, due to the fact that during periods of leave from 
the wards more than one cigarette in a short period of time.  
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³%HFDXVHLW¶VLOOHJDOKHUHVPRNLQJRQ your leave you feel like need to smoke fast, fast, fast, 
fast [in case] something happens.´3Drticipant 1: Male, acute ward). 
³I only get eight half an hour a day, unescorted [leave]. I usually smoke two when I am 
RXW«7KDW¶VEHFDXVHRIWKHOHDYH,QHHGWRPDNHVXUH,NHHSP\QLFRWLQHOHYHOVXS+DYLQJ
WKHRQHFLJDUHWWHQRZLVQRWHQRXJK,¶YHJRWWRKDYHWZR.´[Participant 4, Male; 
Rehabilitation ward]. 
Several participants reported the use of a range of mostly single NRT products to help 
manage their abstinence, ZKLOHRWKHUVKLJKOLJKWHGWKHLUEHOLHILQµJRLQJFROGWXUNH\¶ XVLQJµZLOO
SRZHU¶, and one highlighted the use of electronic cigarettes as an aid to maintain abstinence. 
Despite some critical views, patients appeared overall accepting of the policy.  
µ,WKRXJKWLW>VPRNHIUHHSROLF\@LVQHYHUJRLQJWRZRUNEXWLW«,VXSSRVHLW¶OOKDYHWRZRUN
WKHUHLVQRH[FXVHVQRZLVWKHUH¶ [Participant 5: Male; Acute ward]. 
µIt gets easier DVWLPHJRHVDORQJDQGWKDWEXW,¶GOLNHWRTXLWIXOO\DQGWKDWORWEXWEHFDXVHRI
WKHVWUHVV\RXJRWKURXJKLQKHUH\RXQHHGVRPHWKLQJ¶ [Participant 6: Female; Acute ward]. 
One participant reported that his clozapine dose had been reduced by 50% since he quit 
smoking on admission: µ,I,VPRNHLW¶VDbRXWPOEHFDXVH,¶YHVWRSSHGVPRNLQJWKH\¶YH
reduced it to 200 ml, they keep count of me, is it white cells, and have a look at my white 
FHOOVDQGP\GLDEHWHV¶[Participant 2: Male; Rehabilitation ward]. 
Theme 2:  Policy realities: adherence, enforcement and support 
Many participants described utilising their leave entitlement to smoke covertly within the 
grounds of the unit, vLHZLQJWKHPDVµVPRNLQJEUHDNV¶.  Participants reported developing 
strategies to negotiate nicotine withdrawal, with the majority reporting smoking a number of 
cigarettes while on leave, in order to counter the periods of time that they are unable to 
smoke. Furthermore, the concealment of tobacco and smoking paraphernalia was reported 
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by participants to be common practice, and one which is recognised and even supported by 
some staff members  
³:LWKLQKRXUVRIPHEHLQJKHUH,ZDVDGYLVHGE\WKHVWDIIE\one member of staff, to 
µILQGDVWDVK¶IRUP\FLJDUHWWHVRXWVLGH«,DSSUHFLDWHGKLPGRLQJLW.´   [Participant 4: Male, 
Rehabilitation ward] 
µ,VWDVKHGWKHOLJKWHURXWVLGHEHFDXVHZHDUHQRWDOORZHGOLJKWHUVLQWKHEXLOGLQJVR,KDYH
never, ever smoked in the building, erm, every time I go on leave on me own, I nip to a spot 
where, which I know and that and I have a 2 cigarettes at a time, and I come back in, erm, 
WKDW¶VLWUHDOO\¶[Participant 3:  Female; Acute ward]. 
³<RX¶YHRQO\JRWWRZDONRXWDWDQ\SRLQWLQWKHGD\DQGVRPHRQHLVILGGOLQJDERXWLQWKH
trees or the bushes for the FLJDUHWWHV¶>Participant 8; Male; Rehabilitation ward]. 
One patient however described a different experience of strong policy enforcement that was 
perceived as inappropriate: 
³6RPHSHRSOHKDYHDVWLFNUDPPHGULJKWXSWKHLUEDFNVLGHZKHUHWKH\¶UHFKDOOHQJLQJ
SDWLHQWV7RPHWKDW¶VQRWDZD\WREHZLWKSHRSOHZLWKPHQWDOLOOQHVV«7KH\GRWKDWLQIURQW
RIHYHU\ERG\LQVWHDGRIWDNLQJWKHPWRRQHVLGH´ [Participant 4; Male;  Acute ward]. 
In terms of support, there was evidence of staff offering patients NRT products on 
admission, but no accounts relating to the offer or uptake of behavioural support or any 
information relating to the links of smoking with medication were elicited. While some 
patients reportedly used NRT, they conveyed a sense of a lack of more comprehensive 
support following initial discussions with staff after admission concerning abstinence support: 
IRUH[DPSOH³7KH\MXVWVDLG³:HFDQRIIHU\RXVRPHFKHZLQJJXP´DQGWKDWZDVDERXWLW
[Participant 5; Male; Acute ward].   
Some patients described witnessing staff smoking on Trust premises, alone or with patients: 
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µ,¶YHVHHQDWOHDVWILYHFOHDQHUVVPRNLQJ,¶YHVHHQWKUHHVWDIIRQHIURPWKLVZDUGDQGD
FRXSOHIURPDQRWKHU«,¶YHHYHQVHHQWKHPVPRNLQJZLWKSDWLHQWVDVZHOOVRWKH\¶YHWDNHQ
VRPHERG\IRUDZDONDQGWKH\VLWDQGVPRNHWRJHWKHU¶ [Participant 7; Female; 
Rehabilitation ward]. 
Theme 3:  Challenges to maintaining abstinence and achieving cessation 
Two participants cited boredom and stress as challenges to managing their cravings and 
maintaining abstinence on the wards. Furthermore, there was a notion that a lack of 
knowledge and information with regard to strategies to support stopping smoking, especially 
the use of NRT products, prevailed. Despite all patients receiving a brief smoking cessation 
intervention upon admission many participants displayed a number of misapprehensions 
regarding the use of NRT, resulting in some choosing not to use the products offered.  For 
H[DPSOHRQHSDUWLFLSDQWFODLPHG³When I have a patch or nicotine, it puts nicotine in my 
system and it makes me want mRUH´[Participant 2; Male; Rehabilitation ward], and several 
were relying on will power to manage their cravings alone. There was a lack of 
understanding that electronic cigarettes are substantially less harmful than tobacco smoking, 
, with one participant stating that µQRERG\UHDOO\NQRZV\HWKRZKDUPIXOLWLVIRU\RX¶
[Participant 3; Female; Acute ward].  
Clearly, there was an awareness of covert smoking taking place on Trust premises despite 
the policy, much by way of representing an implicitly accepted norm rather than an 
exception, as demonstrated in previous quotes. Essentially, it became clear during the 
interviews that the new policy could only be considered partial.    
Theme 4:  Motivation to quit and thoughts on smoking after discharge 
Many participants stated they wanted to quit smoking entirely or maintain the reduction of 
consumption they had achieved during the inpatient stay after discharge. Some expressed 
positive notions of the idea to access stop smoking services or harm reduction measures in 
the community following discharge: ³I would like go to a smoke-free clinic´>Participant 
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4:Male, Acute ward].  For some, electronic cigarettes were considered an acceptable 
FHVVDWLRQPHWKRGZLWKRQHSDUWLFLSDQWVWDWLQJ³An e-cig would stop me IURPVPRNLQJIRUOLIH´
[Participant 2: Male; Rehabilitation ward].  One participant highlighted the importance of her 
VRQ¶VDSSURYDORIKHUTXLWWLQJVPRNLQJDVDPRWLYDWRUWRNHHSXSDVPRNHIUHHOLIHVW\OHDIWHU
GLVFKDUJHµThe fact that my son is over the PRRQWKDW,¶YHVWRSSHGVPRNLQJ«WKDW¶VHQRXJK
for me [to stay smokefree]¶[Participant 7; Female; Rehabilitation ward]. 
Drinking coffee and alcohol and watching movies in which characters smoked were cited by 
some participants as potential trigger for relapse when returning home. Several participants 
mentioned that the use of cannabis presented a trigger for smoking relapse: 
µ<HDKZHOOQRZ,¶YHEHHQVWRSSLQJVPRNLQJEXW,NQRZZKHQ,JHWRXW,¶OOSUREDEO\VPRNHD
spliff, so I might end up back on cigarettHV«¶ [Participant 2:  Male; Rehabilitation ward]. 
Notably, one participant reported a lack of encouragement from community health 
professionals in relation to smoking cessation in the context of mental illness: ³If you go to 
the doctors to ask help for stoSVPRNLQJZKLOH\RX¶YHJRWPHQWDOKHDOWKLVVXHVWKH\WHOO\RX
to sort out your mental health issues first´>Participant 3: Female, Acute ward].   Some 
participants mentioned that further information on how to stop smoking, face-to-face and 
group support would help them quit. One stressed that receiving a reward, for making a 
VXFFHVVIXOTXLWDWWHPSWZRXOGEHDQLQFHQWLYHIRUKHUµFor me to stop smoking, there has to 
EHDUHZDUGDWWKHHQGRILWGR\RXNQRZZKDW,PHDQ"«6RPHNLQGRIVSHFLDODZDUG«,
GRQ¶WNQRZOLNHDFHUWLILFDWHRUVRPHWKLQJ¶[Participant 3; Female; Acute ward]. 
DISCUSSION 
This mixed-methods evaluation demonstrates that there are notable challenges in collecting 
relevant and complete data for a comprehensive evaluation of smokefree policies in mental 
health settings that are likely to affect mental health Trusts across the country. Confident 
interpretation of the quantitative evaluation results is therefore in parts limited, especially 
where changes in psychotropic medication prescribing are concerned. Qualitative results 
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indicate the emergence of a number of implementation issues that have the potential to 
result in serious undermining of the policy, with likely adverse effects on patients and staff. 
Despite this, the qualitative data highlighted overall encouraging changes in smoking 
behaviour as well as high motivation to maintain or advance this change after discharge, in 
line with emerging literature[17]. The need to secure enhanced staff and patient support and 
to establish meaningful smoking-related data collection pathways is apparent.  
Supporting patients who smoke 
While the proportion of patients who received recorded enquiries in relation to smoking 
status decreased slightly in the post-PH48 implementation period, the recording of the 
delivery of brief advice, offers, and uptake of treatment for tobacco dependence increased 
considerably, which should be interpreted as encouraging.  However, although more patients 
were provided with NRT according to case note records, observed rates of NRT 
prescriptions within pharmacy records appeared to be low, although this could at least be 
partly explained by the incompleteness of the pharmacy data set we were able to obtain. 
Still, both quantitative and qualitative findings indicate that the prescribing of combination 
NRT, as recommended for the support of heavily dependent smokers[1], is uncommon.   
In the absence of informatioQUHODWLQJWRFKDQJHVRISDWLHQWV¶VPRNLQJVWDWXVDQGRUVPRNLQJ
behaviour following admission, it appears challenging to analyse and interpret the impact of 
smokefree policy implementation in a meaningful and comprehensive way. Furthermore, 
failing to revLHZDQGGLVFXVVSDWLHQWV¶Vmoking at discharge may mean that opportunities for 
supporting patients after discharge to reduce their tobacco consumption or encourage quit 
attempts may be missed[18]. Recent research has shown that post-discharge cessation 
support is effective in motivating quit attempts and reductions in cigarette consumption for up 
to six months post-discharge[19]. In line with NICE[9] and other[2] recommendations, future 
research should consider how best to integrate post discharge support for tobacco 
dependence into community mental health services. 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
22 
 
Policy adherence and enforcement 
One of the most unexpected and salient insights from this project pertained to the apparent 
emergence of practices that resulted in smoking being yet again established as a µnorm¶ ± 
despite the implementation of a complete smokefree policy. Patients in our study reported 
that the grounds of the site provided numerous opportunities to hide tobacco and smoke 
covertly.  Accounts of stashed cigarettes and paraphernalia, of regular smoking on Trust 
premises during leave from the wards, and of staff facilitating and sometimes participating in 
smoking bear close resemblance to findings from research conducted after the first 
implementation of smokefree policies in mental health settings in 2008[6, 20], and before 
NICE guidance PH48 implementation[8]. This research concluded that the establishment of 
implicit pathways that facilitate smoking results in a number of adverse effects. In line with 
findings from the international literature[5, 21-23], the partial rather than comprehensive 
smoke free policy appeared to limit effectiveness in promoting and supporting cessation or 
temporary abstinence among patients and the culture of tobacco use. It was also clear that 
misconceptions related to the use of NRT and electronic cigarettes prevailed, and that the 
recollection and uptake of offers of behavioural support was limited.  
 
Smoking-related incidents  
Our evaluation FRQWDLQHGDQDQDO\VLVRIDOOHYHQWVFODVVHGDVµLQFLGHQWV¶DFFRUGLQJWRTrust 
policies and thus went further than previous studies, which focused on incidents involving 
violence and aggression only[24]. Unsurprisingly, our analysis identified an increase in 
reported illicit smoking following smokefree policy implementation compared to pre-
implementation. However, in common with international studies investigating the 
establishment of smokefree mental health environments, it showed that challenging patient 
behaviours, in particular violent incidents involving staff, fell considerably after the 
implementation of PH48[24-28]. As discussed by Robson et al. in their recent study in a UK 
mental health Trust[24], this is an important finding, seeing as concerns over potential 
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increases in violence are cited as one of the main reasons for mental health Trust¶V
reluctance to implement complete smoking bans rigorously. It is also in line with conclusions 
from international reviews[29, 30], showing that the commonly anticipated surge in violent 
incidents did not transpire. It is worth noting that in our study, recorded incidents of damage 
to property increased from 8% to 28% during the study period. The reasons for this are 
unclear and could be related to a purely descriptive analysis, which did not account for 
potential confounders as other studies with more complex analysis techniques did[24], or to 
enhanced recording practice following implementation should be considered. Continuous 
monitoring of smoking-related incidents should be established as an indicator of smokefree 
policy implementation progress.   
Patient experience and needs 
Although some criticism of the policy was expressed by participants in our study, patients 
reported they were coping with it well ± though in many cases admittedly making use of 
opportunities to smoke covertly on outdoor Trust premises. Nevertheless, in line with other 
emerging evidence[17], a number of participants in our study reported that admission to a 
smokefree hospital hadencouraged contemplation of quitting, and that two of nine previously 
smoking participants were abstinent from tobacco at the time of interview. In line with the 
evidence[3, 4], this challenges the widely held tacit assumption that patients with mental 
health problems are less interested in or less able to quit smoking and highlights the great 
potential of a successfully implemented smokefree policy and the importance of pursing this 
goal. Based on our quantitative findings, anecdotal concerns in relation to patients seeking 
early discharge, at times against clinical advice, appear to be unfounded.   
A number of factors considered likely to trigger relapse to smoking after discharge, including 
the use of cannabis, were mentioned by participants, and overall acceptance expressed 
towards the notion of accessing smoking cessation support, with preferences of types of 
support varying. The need therefore to develop and test support pathways for patients who 
smoke following a smokefree inpatient stay is evident. This is in line with studies from the US 
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and Australia that highlight the potential of post-discharge smoking cessation interventions in 
the community[19, 31]. 
Participants reported misapprehensions and uncertainty of the efficacy of the support 
DYDLODEOH7KLVKLJKOLJKWVWKHQHHGWRIXUWKHUXQGHUVWDQGSDWLHQWV¶SUHIHUHQFHVIRUSUHSDULQJ
for admission to a smokefree setting, and the provision of NRT to support temporary 
abstinence. Furthermore, the need to increase the capacity of staff to effectively identify and 
address gaps in patient knowledge is highlighted. The management of nicotine withdrawal 
should be proactive, with an understanding of evidence-based strategies (including use of of 
combination therapies and supporting temporary abstinence), knowledge of the potential of 
electronic cigarettes as harm reduction aids in this population[32]. The delivery of smoking 
cessation interventions requires staff to acquire skills and knowledge to both understand the 
issues and apply a managed intervention to address both withdrawal and dependence. 
Furthermore, reference to boredom and stress µ\RXQHHGVRPHWKLQJ¶) emphasizes the 
importance of offering therapeutic activities appropriate to support smoking abstinence, in 
addition to comprehensive evidence-based cessation and abstinence support.   
 
Challenges, strengths and limitations 
The findings of this study should be interpreted in light of several limitations. First of all, as 
indicated previously, we encountered substantial difficulties in collecting adequate data for 
some of the study components, especially the component related to potential changes in 
antipsychotic medication. We interpret these difficulties as indicative of challenges likely to 
arise in the context of future evaluations and research studies in this area and feel strongly 
that the development and maintenance of data collection pathways suitable to review 
progress in this area should be highlighted. This is also true for the availability of smoking-
related data that would enable interpretation of policy effects in a more comprehensive way. 
For example, we were unabOHWRFROOHFWDQ\VWUXFWXUHGLQIRUPDWLRQRQFKDQJHVLQSDWLHQWV¶
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smoking behaviour post discharge: smoking status information was only collected on 
admission, and no further information, e.g. usefully on cigarette consumption by the time of 
discharge, was recorded. In the absence of such data, interpretation relating to the effects of 
smokefree policy implementation is difficult. During the project, we endeavoured to initiate 
recording of such data on two pilot wards. This failed due to non-compliance of staff, 
resulting in a pilot data yield that was substantially too small to be considered for analysis.   
Recruitment of participants for the qualitative interviews proved challenging in this population 
and took place opportunistically (in line with qualitative methodology) over several months. It 
is possible that the experiences of those patients who were willing to talk to us are not 
generalizable to all smokers in the study setting. However, despite potential concerns of 
internal and external validity, important unexpected themes emerged in unison across 
accounts, enabling a deeper understanding of processes and underlying issues that 
quantitative data alone would not have provided.  
Another limitation arises from a relatively small  sample of wards from one single Trust, and 
also from the relatively short periods of time data were collected pre- and post- 
implementation (2 months, respectively) that were chosen pragmatically ± in close proximity 
to implementation itself. Long-term assessments of policy impact, supported by appropriate 
data collection pathways, are required to complement short-term findings. 
Nonetheless, to our knowledge, this is the first evaluation of its kind, and despite the 
limitations  constitutes a valuable addition to the scarce evidence in this area, highlighting 
some encouraging results as well as emerging implementation issues. We are confident that 
many of the issues raised here will be relevant for other mental health Trusts in the country, 
and hope that our findings will provide a starting point for the development of further data 
collection and open discourse in this area.   
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CONCLUSION 
Suitable data collection pathways for the meaningful evaluation and interpretation of impacts 
related to smokefree policy implementation in mental health settings are crucial and currently 
not in place. There is an indication and a concern that efforts to implement comprehensive 
policies could be significantly undermined by the establishment of tacitly accepted covert 
smoking rules. The importance of continuous monitoring of processes and outcomes related 
to the policy, of enabling staff to support patients and the policy comprehensively, and of 
creating inpatient environments supportive of managing tobacco abstinence, is highlighted. 
LIST OF ABBREVIATIONS 
 
NICE ± National Institute for Health and Care Excellence 
NRT ± Nicotine Replacement Therapy 
SMI ±  Severe Mental Illness 
 
DECLARATIONS 
 
Ethics approval and consent to participate 
The quantitative element of the project was approved and logged by the Trust R&D 
department as Service Evaluation and Development project in the context of NICE guidance 
PH48 implementation.  The qualitative interview element (face-to-face interviews with 
inpatients) was approved by the London ± Harrow Research Ethics Committee (reference: 
15/LO/2115) in line with national research governance standards. Consent to participate was 
obtained from all interview participants in accordance with these standards.        
 
Consent for Publication 
n/a 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
27 
 
 
Availability of Data and Materials 
The data that support the findings of this study are available from the corresponding author 
and Leeds and Yorkshire Partnership Foundation Trust (LYPFT) upon reasonable request, 
but restrictions apply to the availability of some of these data and so these may not be 
publicly available.  
Competing interests 
None of the authors have competing interests to declare.  
Funding 
This project was funded by the Cancer Research UK (CRUK) Tobacco Advisory Group 
(TAG). The funder had no involvement in the design of the study, or in the collection, 
analysis and interpretation of the data presented.  
One of the authors of this paper (ER) was supported by the NIHR collaboration for 
Leadership in Applied Health Research and Care Yorkshire and Humber (NIHR CLAHRC 
YH), www.clahrc-yh.nihr.ac.uk. The views and opinions expressed are those of the authors 
and not necessarily those of the NHS, the NIHR or the Department of Health.  
 
$XWKRU¶VFRQWULEXWLRQV 
ER conceived the idea for the study and was responsible for all aspects of its design and 
conduct, the analysis and write-up, and overall management and supervision. LH was 
heavily involved in the day-to-day running and management of the study, the data analysis, 
and the production of this manuscript. HS carried out the data collection and contributed to 
the analysis, and to the production of the manuscript. CP contributed to the study design, 
advised during its conduct, and was involved in the production of the manuscript. All authors 
have read and approved the final manuscript.   
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
28 
 
 
Acknowledgements 
We would like to thank the UK Centre for Tobacco Control Studies (UKCTAS), the Leeds 
and Yorkshire Partnership Foundation Trust (LYPFT) and Pamela Mareya for their support in 
the conduct of this project. Special thanks go to the patients of LYPFT who took part in the 
qualitative study.  
REFERENCES 
 
1. Royal College of Physicians and  Royal College of Psychiatrists: Smoking and mental health:  
A joint report by the Royal College of Physicians and the Royal College of Psychiatrists. In. 
London; 2013. 
2. Harker K, Cheeseman H: The Stolen Years: The Mental Health and Smoking Action Report. 
In.: ASH, available at http://www. ash. org. uk/stolenyears; 2016. 
3. Siru R, Hulse GK, Khan RJK, Tait RJ: Motivation to quit smoking among hospitalised 
individuals with and without mental health disorders. Aust Nz J Psychiat 2010, 44(7):640-
647. 
4. Banham L, Gilbody S: Smoking cessation in severe mental illness: what works? Addiction 
2010, 105(7):1176-1189. 
5. Lawn SJ: Systemic barriers to quitting smoking among institutionalised public mental 
health service populations: a comparison of two Australian sites. The International journal 
of social psychiatry 2004, 50(3):204-215. 
6. Ratschen E, Britton J, Doody GA, McNeill A: Smoke-free policy in acute mental health 
wards: avoiding the pitfalls. General hospital psychiatry 2009, 31(2):131-136. 
7. Robson D, Yates M, Craig TJ, Healey A, McNeill A: Time to smoke: facilitating smoking 
breaks in mental health inpatient settings. Nicotine & Tobacco Research 2016:ntw103. 
8. Sohal H, Huddlestone L, Ratschen E: Preparing for Completely Smoke-Free Mental Health 
Settings: Findings on Patient Smoking, Resources Spent Facilitating Smoking Breaks, and 
the Role of Smoking in Reported Incidents from a Large Mental Health Trust in England. 
International journal of environmental research and public health 2016, 13(3). 
9. Smoking Cessation in Secondary Care: Acute, Maternity and Mental Health Services. 
[https://www.nice.org.uk/guidance/ph48] 
10. Department of Health: Towards a smokefree generation: tobacco control plan for England. 
https://www.gov.uk/government/publications/towards-a-smoke-free-generation-
tobacco-control-plan-for-england. In. London; 2017. 
11. Ratschen E, Britton J, McNeill A: The smoking culture in psychiatry: time for change. The 
British journal of psychiatry : the journal of mental science 2011, 198(1):6-7. 
12. Olivier D, Lubman DI, Fraser R: Tobacco smoking within psychiatric inpatient settings: 
biopsychosocial perspective. Australian and New Zealand Journal of Psychiatry 2007, 
41(7):572-580. 
13. Francke AL, Smit MC, de Veer AJ, Mistiaen P: Factors influencing the implementation of 
clinical guidelines for health care professionals: a systematic meta-review. BMC Med 
Inform Decis Mak 2008, 8:38. 
14. Royal College of Physicians, Royal College of Psychiatrists: Smoking and Mental Health. In. 
London; 2013. 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
29 
 
15. ŽǁŶĞ ?tamboldt B: Content analysis: method, applications, and issues. Health care for 
women international 1992, 13(3):313-321. 
16. Pope C, Ziebland S, Mays N: Analysing qualitative data. Bmj 2000, 320(7227):114-116. 
17. Ratschen ES, P.; Horspool, M.; Leahy, M.: Smokefree acute adult mental health inpatient 
wards: the service user experience. E-letter. . Psychiatric Bulletin 2018, 32(12). 
18. Brose LS, Simonavicius E, McNeill A: Maintaining abstinence from smoking after a period of 
enforced abstinence - systematic review, meta-analysis and analysis of behaviour change 
techniques with a focus on mental health. Psychological medicine 2017:1-10. 
19. Stockings EA, Bowman JA, Baker AL, Terry M, Clancy R, Wye PM, Knight J, Moore LH, Adams 
MF, Colyvas K: Impact of a postdischarge smoking cessation intervention for smokers 
admitted to an inpatient psychiatric facility: a randomized controlled trial. nicotine & 
tobacco research 2014:ntu097. 
20. Ratschen E, Britton J, McNeill A: Implementation of smoke-free policies in mental health in-
patient settings in England. The British Journal of Psychiatry 2009, 194(6):547-551. 
21. El-Guebaly N, Cathcart J, Currie S, Brown D, Gloster S: Public health and therapeutic aspects 
of smoking bans in mental health and addiction settings. Psychiatr Serv 2002, 53(12):1617-
1622. 
22. Lawn S, Campion J: Achieving smoke-free mental health services: lessons from the past 
decade of implementation research. International journal of environmental research and 
public health 2013, 10(9):4224-4244. 
23. Lawn S, Pols R: Smoking bans in psychiatric inpatient settings? A review of the research. 
The Australian and New Zealand journal of psychiatry 2005, 39(10):866-885. 
24. Robson D, Spaducci G, McNeill A, Stewart D, Craig TJK, Yates M, Szatkowski L: Effect of 
implementation of a smoke-free policy on physical violence in a psychiatric inpatient 
setting: an interrupted time series analysis. Lancet Psychiatry 2017, 4(7):540-546. 
25. Quinn J, Inman JD, Fadow P: Results of the conversion to a tobacco-free environment in a 
state psychiatric hospital. Administration and Policy in Mental Health and Mental Health 
Services Research 2000, 27(6):451-453. 
26. ĂĚŝĞD ?> ? ?ŶŐƵƐ ?< ? ?DƵƌƌĂǇ ?Z ? ?K ?DĂƌĂ-Eves, A.; Stansfield, C.; Leonardi-Bee, J.: Review 
7: A Review of the Barriers to and Facilitators for Implementing Smokefree Strategies and 
Interventions in Secondary Care Settings.   NICE Evidence Reviews: Smoking Cessation 
Acute, Maternity and Mental Health Services. In.: NICE; 2013. 
27. ŶŐƵƐ <D ? Z ? ? DĂĐŽŶĂůĚ ? > ? ? ĂĚŝĞ ?  ? ? K ?DĂƌĂ-Eves, A.; Stansfield, C.; Leonardi-Bee, J.: 
Review 6: A Review of the Effectiveness of Smokefree Strategies and Interventions in 
Secondary Care Settings. NICE Evidence Reviews: Smoking Cessation Acute, Maternity and 
Mental Health Services. In.: NICE; 2013. 
28. Moss TG, Weinberger AH, Vessicchio JC, Mancuso V, Cushing SJ, Pett M, Kitchen K, Selby P, 
George TP: A Tobacco Reconceptualization in Psychiatry: Toward the Development of 
dŽďĂĐĐŽ ?&ƌĞĞWƐǇĐŚŝĂƚƌŝĐ&ĂĐŝůŝƚies. The American Journal on Addictions 2010, 19(4):293-311. 
29. Lawn S, Pols R: Smoking bans in psychiatric inpatient settings? A review of the research. 
Australian and New Zealand Journal of Psychiatry 2005, 39(10):866-885. 
30. el-Guebaly N, Cathcart J, Currie S, Brown D, Gloster S: Public health and therapeutic aspects 
of smoking bans in mental health and addiction settings. Psychiatric services 2002, 
53(12):1617-1622. 
31. Prochaska JJ, Hall SE, Delucchi K, Hall SM: Efficacy of initiating tobacco dependence 
treatment in inpatient psychiatry: a randomized controlled trial. American journal of public 
health 2014, 104(8):1557-1565. 
32. Ratschen E: Electronic cigarettes in mental health settings - solving a conundrum? Psychiatr 
Bull (2014) 2014, 38(5):226-229. 
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
Huddlestone et al.: Complete smokefree policies in mental health inpatient settings: Results from a 
mixed-methods evaluation before and after implementing national guidance  
 
 
TABLES 1-3 
Table 1: Patient characteristics, by cohort 
Smoking status recorded Frequency (%) 
Pre-PH48 (n=150) Post-PH48 (n=165) 
Current smoker 70 (46.7) 65 (39.3) 
Former smoker 18 (12.0) 20 (12.1) 
Never smoker 23 (15.3) 23 (13.9) 
Unknown 30 (20.0) 31 (18.8) 
Information refused 1 (0.7) 3 (1.8) 
Unrecorded 8 (5.3) 23 (13.9) 
Table 2: Recording of smoking related information during the pre- and post PH48 implementation 
periods 
 
Medication  Pre-PH48 Post-PH48 
n=76 Mean dose (SD) n=40 Mean dose (SD) 
Amitriptyline - - 2 20.0mg  (0.0) 
Chloropromazine - - 2 12.0mg (0.0) 
Clozapine 2 325.0mg (106.1) 4 281.2mg (132.5) 
Diazepam 8 21.9mg (32.7) 4 7.6mg (3.3) 
Duloxetine 2 120.0mg (0.0) 2 90.0mg (0.0) 
Flupenhixol 2 6.0mg (4.2) - - 
Flupenhixol Deconate* 2 260.0mg (197.9) - - 
Haloparidol 7 11.3mg (7.2) 4 9.1mg (5.6) 
Haloparidol Depot* 3 116.6mg (28.9) 3 133.3mg (28.9) 
Lorazepam 7 1.1mg (0.47) 5 1.1mg (0.54) 
Mirtazapine 12 37.5mg (10.1) 9 29.4mg (14.5) 
Olanzapine 37 10.2mg (5.6) 19 9.1mg (4.8) 
Tamazepam 1 40.0mg (-) - - 
Zuclopenhixol 5 110.0mg (82.2) 4 54.7mg (41.8) 
Zuclopenhixol Deconate* 6 1050.0mg (234.5) 5 1600.0mg (489.9) 
 
7DEOH$JJUHJDWHGGRVHVIRUSDWLHQWV¶SUHVFULEHGUHOHYDQWSV\FKRWURSLFPHGLFDWLRQE\3+
implementation period 
Characteristics Pre-
implementation 
(n=150) 
Post-
implementation 
(n=165) 
Frequency (%) 
Gender Male 83 (55.3) 81 (49.1) 
 Female 67 (44.7) 84 (50.9) 
Legal status Detained 81 (54.0) 108 (65.6) 
 Voluntary 69 (46.0) 57 (34.4) 
First admission Yes 43 (28.7) 77 (46.7) 
 No 107 (71.3) 88 (53.3) 
 Mean (SD) 
Age (years) 47.9 (20.9) 48.2 (19.8) 
Length of admission (days) 23.2 (15.9) 37.2 (22.8) 
7DEOH &OLFNKHUHWRGRZQORDG7DEOH%0&B&58.SDSHUB(5B7DEOHVGRF[
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